626 related articles for article (PubMed ID: 29675844)
1. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
2. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
3. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
[TBL] [Abstract][Full Text] [Related]
5. Nanotherapy for posterior eye diseases.
Kaur IP; Kakkar S
J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
[TBL] [Abstract][Full Text] [Related]
6. Ocular Drug Delivery.
Yavuz B; Kompella UB
Handb Exp Pharmacol; 2017; 242():57-93. PubMed ID: 27783270
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A delivery to the eye: a pharmaceutical challenge.
Lallemand F; Felt-Baeyens O; Besseghir K; Behar-Cohen F; Gurny R
Eur J Pharm Biopharm; 2003 Nov; 56(3):307-18. PubMed ID: 14602172
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
[TBL] [Abstract][Full Text] [Related]
11. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
12. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
13. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
14. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
15. Principles of pharmacology in the eye.
Awwad S; Mohamed Ahmed AHA; Sharma G; Heng JS; Khaw PT; Brocchini S; Lockwood A
Br J Pharmacol; 2017 Dec; 174(23):4205-4223. PubMed ID: 28865239
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Rupenthal ID
Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
[TBL] [Abstract][Full Text] [Related]
17. Can (Natural) deep eutectic systems increase the efficacy of ocular therapeutics?
Sarmento C; Duarte ARC; Rita Jesus A
Eur J Pharm Biopharm; 2024 May; 198():114276. PubMed ID: 38582179
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
